|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
RESEARCH ARTICLE |
1 Departments of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Calgary, 3330 Hospital Drive, NW, Calgary, Alberta T2N 4N1, Canada
2 Department of Oncology, Faculty of Medicine, The University of Calgary, 3330 Hospital Drive, NW, Calgary, Alberta T2N 4N1, Canada
*Author for correspondence (e-mail: karl{at}ucalgary.ca)
Accepted June 15, 2001
Previous studies have shown that UV-induced binding of p21WAF1 to PCNA through the PCNA-interacting protein (PIP) domain in p21WAF1 promotes a switch from DNA replication to DNA repair by altering the PCNA protein complex. Here we show that the p33ING1b isoform of the ING1 candidate tumour suppressor contains a PIP domain. UV rapidly induces p33ING1b to bind PCNA competitively through this domain, a motif also found in DNA ligase, the DNA repair-associated FEN1 and XPG exo/endonucleases, and DNA methyltransferase. Interaction of p33ING1b with PCNA occurs between a significant proportion of ING1 and PCNA, increases more than tenfold in response to UV and is specifically inhibited by overexpression of p21WAF1, but not by p16MTS1, which has no PIP sequence. In contrast to wild-type p33ING1b, ING1 PIP mutants that do not bind PCNA do not induce apoptosis, but protect cells from UV-induced apoptosis, suggesting a role for this PCNA-p33ING1b interaction in eliminating UV-damaged cells through programmed cell death. These data indicate that ING1 competitively binds PCNA through a site used by growth regulatory and DNA damage proteins, and may contribute to regulating the switch from DNA replication to DNA repair by altering the composition of the PCNA protein complex.
Key words: Apoptosis, DNA damage, ING1, PCNA, PIP
This article has been cited by other articles:
![]() |
M. Garate, E. I. Campos, J. A. Bush, H. Xiao, and G. Li Phosphorylation of the tumor suppressor p33ING1b at Ser-126 influences its protein stability and proliferation of melanoma cells FASEB J, November 1, 2007; 21(13): 3705 - 3716. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-H. Yuan, Y.-M. Jeng, H.-W. Pan, F.-C. Hu, P.-L. Lai, P.-H. Lee, and H.-C. Hsu Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma Clin. Cancer Res., September 15, 2007; 13(18): 5368 - 5376. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Coles, H. Liang, Z. Zhu, C. G.A. Marfella, J. Kang, A. N. Imbalzano, and S. N. Jones Deletion of p37Ing1 in Mice Reveals a p53-Independent Role for Ing1 in the Suppression of Cell Proliferation, Apoptosis, and Tumorigenesis Cancer Res., March 1, 2007; 67(5): 2054 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Feng, S. Bonni, and K. Riabowol HSP70 Induction by ING Proteins Sensitizes Cells to Tumor Necrosis Factor Alpha Receptor-Mediated Apoptosis Mol. Cell. Biol., December 15, 2006; 26(24): 9244 - 9255. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and G. Li ING3 Promotes UV-induced Apoptosis via Fas/Caspase-8 Pathway in Melanoma Cells J. Biol. Chem., April 28, 2006; 281(17): 11887 - 11893. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gong, M. Russell, K. Suzuki, and K. Riabowol Subcellular Targeting of p33ING1b by Phosphorylation-Dependent 14-3-3 Binding Regulates p21WAF1 Expression Mol. Cell. Biol., April 15, 2006; 26(8): 2947 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, M. Y. Chin, and G. Li The Novel Tumor Suppressor p33ING2 Enhances Nucleotide Excision Repair via Inducement of Histone H4 Acetylation and Chromatin Relaxation Cancer Res., February 15, 2006; 66(4): 1906 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. K. Mukhopadhyay, A. M. Senderowicz, and G. Ferbeyre RNA Silencing of Checkpoint Regulators Sensitizes p53-Defective Prostate Cancer Cells to Chemotherapy while Sparing Normal Cells Cancer Res., April 1, 2005; 65(7): 2872 - 2881. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.Y. He, C. C. Helbing, M. J. Wagner, C. W. Sensen, and K. Riabowol Phylogenetic Analysis of the ING Family of PHD Finger Proteins Mol. Biol. Evol., January 1, 2005; 22(1): 104 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vieyra, D. L. Senger, T. Toyam, H. Muzik, P. M. A. Brasher, R. N. Johnston, K. Riabowol, and P. A. Forsyth Altered Subcellular Localization and Low Frequency of Mutations of ING1 in Human Brain Tumors Clin. Cancer Res., December 1, 2003; 9(16): 5952 - 5961. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shan, J. Xu, Y. Zhuo, C. A. Morris, and G. F. Morris Induction of p53-dependent Activation of the Human Proliferating Cell Nuclear Antigen Gene in Chromatin by Ionizing Radiation J. Biol. Chem., November 7, 2003; 278(45): 44009 - 44017. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kameyama, C.-l. Huang, D. Liu, D. Masuya, T. Nakashima, S. Sumitomo, Y. Takami, M. Kinoshita, and H. Yokomise Reduced ING1b Gene Expression Plays an Important Role in Carcinogenesis of Non-Small Cell Lung Cancer Patients Clin. Cancer Res., October 15, 2003; 9(13): 4926 - 4934. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maga and U. Hubscher Proliferating cell nuclear antigen (PCNA): a dancer with many partners J. Cell Sci., August 1, 2003; 116(15): 3051 - 3060. [Abstract] [Full Text] [PDF] |
||||
![]() |
G S Nouman, J J Anderson, J Lunec, and B Angus The role of the tumour suppressor p33ING1b in human neoplasia J. Clin. Pathol., July 1, 2003; 56(7): 491 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Choy and S. J. Kron NuA4 Subunit Yng2 Function in Intra-S-Phase DNA Damage Response Mol. Cell. Biol., December 1, 2002; 22(23): 8215 - 8225. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Kedar, S.-J. Kim, A. Robertson, E. Hou, R. Prasad, J. K. Horton, and S. H. Wilson Direct Interaction between Mammalian DNA Polymerase beta and Proliferating Cell Nuclear Antigen J. Biol. Chem., August 16, 2002; 277(34): 31115 - 31123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vieyra, R. Loewith, M. Scott, P. Bonnefin, F.-M. Boisvert, P. Cheema, S. Pastyryeva, M. Meijer, R. N. Johnston, D. P. Bazett-Jones, et al. Human ING1 Proteins Differentially Regulate Histone Acetylation J. Biol. Chem., August 9, 2002; 277(33): 29832 - 29839. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vieyra, T. Toyama, Y. Hara, D. Boland, R. Johnston, and K. Riabowol ING1 Isoforms Differentially Affect Apoptosis in a Cell Age-dependent Manner Cancer Res., August 1, 2002; 62(15): 4445 - 4452. [Abstract] [Full Text] [PDF] |
||||